uniQure: Walid Abi-Saab earns 18,750 performance shares

The earned units represent contingent rights to ordinary shares, with vesting subject to regulatory clearance, a January 20, 2027 date and continued employment.

Available on EDGAR 11/03/2026 - 05:10 PM EST Accepted by SEC EDGAR 11/03/2026 - 05:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

uniQure N.V. Chief Medical Officer Walid Abi-Saab earned 18,750 performance-based restricted share units (PRSUs) on October 30, 2026, after certain regulatory milestones were satisfied. Granted January 20, 2026 under the 2014 Share Incentive Plan, each PRSU is a contingent right to receive one ordinary share. Vesting is on the later of 10 business days after receipt of certain regulatory clearance and January 20, 2027, subject to continued employment. His reported resulting direct position was 166,985 ordinary shares.

Insider Trade Summary

Grant/Award: 18,750 shares

Grant/Award 1 txn

Insider Abi-Saab Walid

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	18,750	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 166,985 shares (Direct)

Holdings Before and After: Ordinary Shares, 148,235 to 166,985 shares (Direct)

Footnotes (1)

1. F1. Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on January 20, 2026 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on October 30, 2026 as the result of the satisfaction of certain regulatory milestones. Each PRSU represents the contingent right to receive one Ordinary Share. These shares will vest on the later of (i) 10 business days after the receipt of certain regulatory clearance and (ii) January 20, 2027, subject to the Reporting Person's continued employment by the Issuer through such vesting date.

Key Figures

PRSUs earned: 18,750 PRSUs Resulting direct ordinary shares: 166,985 shares PRSU grant date: January 20, 2026 +2 more

5 metrics

PRSUs earned 18,750 PRSUs Earned October 30, 2026 after certain regulatory milestones were satisfied.

Resulting direct ordinary shares 166,985 shares Reported following the October 30, 2026 transaction.

PRSU grant date January 20, 2026 Granted under the 2014 Share Incentive Plan.

Vesting interval after clearance 10 business days Vesting is on the later of this interval after receipt of certain regulatory clearance and January 20, 2027.

Vesting date threshold January 20, 2027 Vesting is on the later of this date and 10 business days after receipt of certain regulatory clearance.

Key Terms

performance-based restricted share units, contingent right, regulatory clearance, 2014 Share Incentive Plan

4 terms

performance-based restricted share units financial

"Represents performance-based restricted share units (PRSUs) granted"

Performance-based restricted share units are promises to give company stock to employees or executives only if the business hits specified targets, such as revenue, profit or stock performance; think of them as a bonus paid in shares that only vests when certain goals are met. They matter to investors because they align management incentives with shareholder outcomes, can dilute share count when paid out, and reveal how leadership is being rewarded and what milestones the company expects to reach.

contingent right financial

"Each PRSU represents the contingent right to receive one Ordinary Share."

regulatory clearance regulatory

"after the receipt of certain regulatory clearance"

Regulatory clearance is official permission from a government agency to market, sell, or use a product or service after it meets required safety, quality, or performance standards. For investors it matters because receiving clearance often unlocks revenue, lowers legal and commercial risk, and can materially change a company’s growth outlook—think of it like a driver’s license that legally allows a product to be driven onto the market.

2014 Share Incentive Plan financial

"under the Issuer's 2014 Share Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QURE PRSUs did Walid Abi-Saab earn?

Walid Abi-Saab earned 18,750 performance-based restricted share units (PRSUs) on October 30, 2026, after certain regulatory milestones were satisfied. Each PRSU represents a contingent right to receive one ordinary share.

When do Walid Abi-Saab's QURE PRSUs vest?

The PRSUs vest on the later of 10 business days after receipt of certain regulatory clearance and January 20, 2027, subject to Walid Abi-Saab's continued employment through the vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Abi-Saab Walid

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM 1105BP

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/30/2026		A		18,750(1)	A	$0	166,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on January 20, 2026 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on October 30, 2026 as the result of the satisfaction of certain regulatory milestones. Each PRSU represents the contingent right to receive one Ordinary Share. These shares will vest on the later of (i) 10 business days after the receipt of certain regulatory clearance and (ii) January 20, 2027, subject to the Reporting Person's continued employment by the Issuer through such vesting date.

	/s/ Christian Klemt, Attorney-in-Fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)